CLNN

SEC source: 0001437749-26-030730 · rdgdoc.xml · nonDerivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 912,275

F1 · ownership.direct: Mr. Matlin purchased 434,451 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001437749-26-030729 · rdgdoc.xml · nonDerivative · entry 1

Etherington Robert Dee · CIK 0001835330 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,393

F1 · ownership.direct: Mr. Etherington purchased 15,244 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001437749-26-030728 · rdgdoc.xml · nonDerivative · entry 1

Mosca Alison · CIK 0001835537 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By LLC

Disclosed balance after: 478,671

F1 · balance_after: Kensington Clene 2021, LLC purchased 198,171 shares of common stock of Clene Inc. for a purchase price of $3.28 per share in a registered direct offering directly from the Issuer. The issuance of such securities was approved by the Issuer's board of directors in accordance with Rule 16 (b)-3 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: The securities are owned by Kensington Clene 2021, LLC. Ms. Mosca is the sole manager of and owns a minority interest in Kensington Clene 2021, LLC. The securities owned by Kensington Clene 2021, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by Kensington Clene 2021, LLC for which she does not have a pecuniary or profits interest.

SEC source: 0001437749-26-027973 · rdgdoc.xml · derivative · entry 1

Kiernan Matthew · CIK 0001993183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,195

Underlying: common stock · 3,195 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 3,195 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-027965 · rdgdoc.xml · derivative · entry 1

McLaughlin Vallerie · CIK 0001876030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,514

Underlying: common stock · 3,514 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 3,514 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-027966 · rdgdoc.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: common stock · 3,794 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 3,794 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-027964 · rdgdoc.xml · derivative · entry 1

WILCOX REED N · CIK 0001266609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,514

Underlying: common stock · 3,514 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 3,514 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-027968 · rdgdoc.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,230

Underlying: common stock · 6,230 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 6,230 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-027971 · rdgdoc.xml · derivative · entry 1

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,674

Underlying: common stock · 3,674 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 3,674 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-027970 · rdgdoc.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,872

Underlying: common stock · 4,872 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 4,872 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-027967 · rdgdoc.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,752

Underlying: common stock · 4,752 shares

Expires 2036-08-12

F1 · derivative.exercise_date: This option was granted on August 13, 2026 as an option for 4,752 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

SEC source: 0001835544-26-000022 · primary_doc.xml · derivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II LLC

Disclosed balance after: 0

Underlying: Common Stock · 424,358 shares

Expires 2029-09-30

F1 · kind: The Reporting Person was deemed to beneficially own the Warrants reported herein indirectly through SymBiosis II, LLC (the "Fund") by virtue of the Reporting Person's role as Managing Partner of the Fund and the resulting voting and investment power over the Fund's holdings. Effective July 17, 2026, management of the Fund's investment portfolio was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to have voting or investment power over the securities held by the Fund, including the Warrants. Accordingly, the Reporting Person no longer beneficially owns the Warrants reported herein. No consideration was paid or received in connection with this change, and no Warrants were exercised, sold, or transferred.

F3 · price: The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received.

F2 · derivative.exercise_date: Currently exercisable

SEC source: 0001835544-26-000022 · primary_doc.xml · derivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II LLC

Disclosed balance after: 0

Underlying: Common Stock · 375,000 shares

Expires 2030-06-16

F1 · kind: The Reporting Person was deemed to beneficially own the Warrants reported herein indirectly through SymBiosis II, LLC (the "Fund") by virtue of the Reporting Person's role as Managing Partner of the Fund and the resulting voting and investment power over the Fund's holdings. Effective July 17, 2026, management of the Fund's investment portfolio was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to have voting or investment power over the securities held by the Fund, including the Warrants. Accordingly, the Reporting Person no longer beneficially owns the Warrants reported herein. No consideration was paid or received in connection with this change, and no Warrants were exercised, sold, or transferred.

F3 · price: The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received.

F2 · derivative.exercise_date: Currently exercisable

SEC source: 0001437749-26-020637 · rdgdoc.xml · derivative · entry 1

Mortenson Mark · CIK 0001835427 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: common stock · 45,000 shares

Expires 2036-06-10

F1 · derivative.exercise_date: This option was granted on June 11, 2026 as an option for 45,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.

SEC source: 0001437749-26-020635 · rdgdoc.xml · derivative · entry 1

BROWN MORGAN R · CIK 0001266062 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: common stock · 15,000 shares

Expires 2036-06-10

F1 · derivative.exercise_date: This option was granted on June 11, 2026 as an option for 15,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.

SEC source: 0001437749-26-020636 · rdgdoc.xml · derivative · entry 1

Etherington Robert Dee · CIK 0001835330 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: common stock · 65,000 shares

Expires 2036-06-10

F1 · derivative.exercise_date: This option was granted on June 11, 2026 as an option for 65,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.

SEC source: 0001437749-26-018216 · rdgdoc.xml · derivative · entry 2

Kiernan Matthew · CIK 0001993183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,876

Underlying: common stock · 1,876 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,876 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018216 · rdgdoc.xml · derivative · entry 1

Kiernan Matthew · CIK 0001993183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001437749-26-018221 · rdgdoc.xml · derivative · entry 2

McLaughlin Vallerie · CIK 0001876030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,064

Underlying: common stock · 2,064 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018221 · rdgdoc.xml · derivative · entry 1

McLaughlin Vallerie · CIK 0001876030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001437749-26-018215 · rdgdoc.xml · derivative · entry 2

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,228

Underlying: common stock · 2,228 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 2,228 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018215 · rdgdoc.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001437749-26-018214 · rdgdoc.xml · derivative · entry 2

WILCOX REED N · CIK 0001266609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,064

Underlying: common stock · 2,064 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018214 · rdgdoc.xml · derivative · entry 1

WILCOX REED N · CIK 0001266609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001437749-26-018218 · rdgdoc.xml · derivative · entry 2

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,659

Underlying: common stock · 3,659 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 3,659 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018218 · rdgdoc.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001437749-26-018219 · rdgdoc.xml · derivative · entry 2

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,861

Underlying: common stock · 2,861 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 2,861 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018219 · rdgdoc.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001437749-26-018220 · rdgdoc.xml · derivative · entry 2

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,158

Underlying: common stock · 2,158 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 2,158 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018220 · rdgdoc.xml · derivative · entry 1

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001437749-26-018217 · rdgdoc.xml · derivative · entry 2

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,791

Underlying: common stock · 2,791 shares

Expires 2036-05-20

F2 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 2,791 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

SEC source: 0001437749-26-018217 · rdgdoc.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,500

Underlying: common stock · 1,500 shares

Expires 2036-05-20

F1 · derivative.exercise_date: This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

SEC source: 0001835544-26-000019 · primary_doc.xml · nonDerivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 103,417

SEC source: 0001835544-26-000019 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 176,713

SEC source: 0001835544-26-000018 · primary_doc.xml · nonDerivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 198,890

SEC source: 0001835544-26-000018 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 271,774

SEC source: 0001835544-26-000017 · primary_doc.xml · nonDerivative · entry 3

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 277,569

SEC source: 0001835544-26-000017 · primary_doc.xml · nonDerivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 283,305

SEC source: 0001835544-26-000017 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 295,475

SEC source: 0001835544-26-000016 · primary_doc.xml · nonDerivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 297,066

SEC source: 0001835544-26-000016 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 358,411

SEC source: 0001835544-26-000015 · primary_doc.xml · nonDerivative · entry 3

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 362,729

SEC source: 0001835544-26-000015 · primary_doc.xml · nonDerivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 387,769

SEC source: 0001835544-26-000015 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 395,517

SEC source: 0001835544-26-000014 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 401,891

SEC source: 0001835544-26-000013 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 426,816

SEC source: 0001835544-26-000012 · primary_doc.xml · nonDerivative · entry 3

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Symbiosis II, LLC

Disclosed balance after: 431,094

SEC source: 0001835544-26-000012 · primary_doc.xml · nonDerivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 499,085

SEC source: 0001835544-26-000012 · primary_doc.xml · nonDerivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 514,621

SEC source: 0001835544-26-000011 · primary_doc.xml · nonDerivative · entry 3

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By SymBiosis II, LLC

Disclosed balance after: 532,091